Literature DB >> 8618907

Stimulation of protective CD8+ T lymphocytes by vaccination with nonliving bacteria.

G Szalay1, C H Ladel, S H Kaufmann.   

Abstract

Infectious diseases caused by intracellular microbes are responsible for major health problems, and satisfactory control will ultimately depend on efficient vaccination strategies. The general assumption is that activation of protective immune responses against intracellular microbes dominated by CD8+ T cells are achieved only by live vaccines. In contrast, we here demonstrate stimulation of protective immunity in mice against the intracellular pathogen Listeria monocytogenes by vaccination with heat-killed listeriae. Vaccine-induced immunity comprised cytolytic and interferon gamma-producing CD8+ T lymphocytes. CD8+ T cells from vaccinated donor mice transferred protection against listeriosis. Moreover, vaccination with heat-killed listeriae induced production in CD4+ T-cell-deficient, H2-A beta gene-disrupted mutant mice. We conclude that antigens from killed listeriae are introduced into the major histocompatibility complex class I pathway and thus are recognized by CD8+ T cells. The practicability of killed vaccines against human infectious diseases therefore should be reevaluated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618907      PMCID: PMC40363          DOI: 10.1073/pnas.92.26.12389

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

2.  Synthetic vaccines. Peptides of fortune.

Authors:  C Janeway
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

Review 3.  CD8+ T lymphocytes in intracellular microbial infections.

Authors:  S H Kaufmann
Journal:  Immunol Today       Date:  1988-06

4.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

5.  Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth.

Authors:  L M Brunt; D A Portnoy; E R Unanue
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

6.  Mice lacking MHC class II molecules.

Authors:  D Cosgrove; D Gray; A Dierich; J Kaufman; M Lemeur; C Benoist; D Mathis
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

7.  Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity.

Authors:  S H Kaufmann; H R Rodewald; E Hug; G De Libero
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

8.  Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes.

Authors:  E G Pamer; J T Harty; M J Bevan
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

9.  Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1990-02-01       Impact factor: 14.307

10.  Role of hemolysin for the intracellular growth of Listeria monocytogenes.

Authors:  D A Portnoy; P S Jacks; D J Hinrichs
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  12 in total

1.  gp96-peptide vaccination of mice against intracellular bacteria.

Authors:  U Zügel; A M Sponaas; J Neckermann; B Schoel; S H Kaufmann
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.

Authors:  R S Friedman; F R Frankel; Z Xu; J Lieberman
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product.

Authors:  Xinyan Zhao; Zhongxia Li; Baiyan Gu; Fred R Frankel
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox.

Authors:  Dev Chandran; Sureddi Satyam Naidu; Parthasarathy Sugumar; Gudavalli Sudha Rani; Shahana Pallichera Vijayan; Deepika Mathur; Lalit C Garg; Villuppanoor Alwar Srinivasan
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

5.  Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis.

Authors:  C P Simmons; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Immunization against the agent of human granulocytic ehrlichiosis in a murine model.

Authors:  W Sun; J W IJdo; S R Telford; E Hodzic; Y Zhang; S W Barthold; E Fikrig
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

7.  Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12.

Authors:  Y Emoto; M Emoto; S H Kaufmann
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

8.  Bacterial and host factors involved in the major histocompatibility complex class Ib-restricted presentation of Salmonella Hsp 60: novel pathway.

Authors:  Wei-Feng Lo; Cory D Dunn; Helena Ong; Eleanor S Metcalf; Mark J Soloski
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 9.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth.

Authors:  R J Thompson; H G Bouwer; D A Portnoy; F R Frankel
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.